M. Brian Mulroney et Mme Mila Mulroney (credit: Peter Bregg)
The Right Honourable Brian Mulroney and Mrs Mila Mulroney are pleased to announce their personal gift of $1.5 million to the foundations of the Montreal Clinical Research Institute (IRCM), the Centre hospitalier de l'Université de Montréal (CHUM) and the Montreal Heart Institute (MHI) , each of which will be receiving $500,000.
With a law degree from Université Laval, Mr. Mulroney, a great philanthropist has demonstrated in recent years his dedication to Quebec institutions that have an impact on society. Having focused on education, Mr. and Mrs. Mulroney now want to contribute to health care.
In recent years, former Prime Minister Mulroney has received oncology treatment at the CHUM from Drs. Paul Perrotte and Cynthia Ménard, at the Montreal Heart Institute from Drs. Jean-Lucien Rouleau, Shaun Selcer and Philippe Lavoie-L’Allier, and at the Montreal Clinical Research Institute (IRCM) from Dr. Rémi Rabasa-Lhoret.
"Like many others, I have been affected by disease. I want to reiterate how grateful I am to have been cared for by the competent and talented teams at these two hospitals and this research institute. With this donation, I would like to express my gratitude for their exemplary professionalism and exceptional contribution to our healthcare system," says Mr. Mulroney.
"We are touched by this gesture, which encourages and motivates us in our mission to offer specialized care that improves the daily lives of people living with rare or complex diseases, including certain forms of diabetes," said Dr. Rémi Rabasa-Lhoret, Vice President Clinical Research, Director of the IRCM Diabetes Clinic, and Mr. Mulroney's attending physician.
"On behalf of our teams and those living with diabetes, we extend our heartfelt thanks to Brian and Mila Mulroney for their generous support and trust," said Marie-Bénédicte Pretty, Executive Director of the IRCM Foundation. At the IRCM Foundation, this donation will enable us to propel innovative projects aimed at improving care, developing more effective treatments and training the next generation of scientists."
